Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Changing the Perception of Your Product

As if healthcare marketing wasn’t already difficult enough, companies that treat taboo health concerns face a unique set of problems. How do you change people’s perception of your product to account for this? And how do you get your product in front of the people who need it most? These are the questions that…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

As if healthcare marketing wasn’t already difficult enough, companies that treat taboo health concerns face a unique set of problems. How do you change people’s perception of your product to account for this? And how do you get your product in front of the people who need it most?

These are the questions that Caronline Goodner, the CEO of OrganiCare, wrestles with every day. On today’s episode, she discusses creative ways to market products like FemiClear that are usually seen as taboo in many industries.

About 775,000 people are diagnosed with genital herpes every year. Despite how common the disease is, many people feel uncomfortable talking about this issue and choose to suffer in silence instead.

But thanks to advances in digital marketing, OrganiCare is able to market an organic OTC herpes medication to these people in a discreet way. They’re going to be looking for information on the internet, after all, and Goodner hopes to provide them with the solution they need.

Her work doesn’t stop there, however. To combat the skepticism that comes with marketing an all-natural solution to herpes, Goodner must convey the credibility of the science behind the medication. How? With results from extensive lab and consumer testing, as well as a highly credible medical board that vouches for the product as well. She reinforces the fact that all of OrganiCare’s claims must be backed by hard evidence, and they conduct their marketing efforts with that in mind.

Over the years, those with genital herpes have formed groups to support each other and find solutions to their unique concerns. Goodner hopes to bring FemiClear into these discussions in a helpful, rather than forceful, way. This focus on education rather than selling helps OrganiCare and companies like them successfully reach their intended audience.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512